Breaking News

Cytocom Acquires ImQuest Life Sciences

Gains ImQuest Pharmaceuticals, BioSciences, and Life Sciences divisions, adding drug development and CRO ops, and pipeline assets.

By: Contract Pharma

Contract Pharma Staff

Cytocom, Inc., a clinical-stage biopharmaceutical company developing novel immune modulating therapies, has acquired ImQuest Life Sciences, Inc., a research and development company focused on cancer, inflammation and infectious disease treatments, including its subsidiaries in an all-stock transaction. ImQuest Pharmaceuticals, the drug development arm of ImQuest Life Sciences, will be merged into Cytocom’s existing drug development operations. ImQuest BioSciences, a contract research o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters